Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie H Rowe

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Gastrointestinal Oncology|March 23, 2018
How does the tumor microenvironment play a role in hepatobiliary tumors?Fathima Kamil, Julie H Rowe
Journal of Carcinogenesis|July 12, 2017
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesisYezaz Ahmed Ghouri, Idrees Mian, Julie H Rowe
Journal of Geriatric Oncology|June 18, 2016
Geriatrics: Year in reviewHolly M Holmes, Maureen S Beck, Julie H Rowe
Clinical Nuclear Medicine|July 24, 2023
False-Positive 68 Ga-DOTATATE Uptake in a Uterine Subserosal Fibroid Mimicking Mesenteric Neuroendocrine Tumor : A Case StudyKamand Khalaj, Julie H Rowe, Chakradhar R Thupili, et al.
Targeted Oncology|April 19, 2011
Mammalian target of rapamycin as a target in hematological malignanciesKevin R Kelly, Julie H Rowe, Swaminathan Padmanabhan, et al.
Journal of Hepatocellular Carcinoma|April 2, 2026
Evaluation of Prophylactic EGD versus Beta Blockade in Hepatocellular Carcinoma Patients on Anti-Angiogenic Cancer TreatmentsPanayiotis D Kontoyiannis, Camila Ayerbe, Kok Hoe Chan, et al.
British Journal of Cancer|February 9, 2023
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancerJoan Jacob, Liezl E Francisco, Treena Chatterjee, et al.
Gastrointestinal Endoscopy|May 10, 2024
EUS-guided radiofrequency ablation for pancreatic adenocarcinomaCurtis J Wray, Baylee O'Brien, Putao Cen, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal CancerJoan Jacob, Yasuaki Anami, Peyton High, et al.
British Journal of Cancer|August 18, 2025
Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancerYukimatsu Toh, Ling Wu, Jianghua Tu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Gastrointestinal Oncology|March 23, 2018
How does the tumor microenvironment play a role in hepatobiliary tumors?Fathima Kamil, Julie H Rowe
Journal of Carcinogenesis|July 12, 2017
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesisYezaz Ahmed Ghouri, Idrees Mian, Julie H Rowe
Journal of Geriatric Oncology|June 18, 2016
Geriatrics: Year in reviewHolly M Holmes, Maureen S Beck, Julie H Rowe
Clinical Nuclear Medicine|July 24, 2023
False-Positive 68 Ga-DOTATATE Uptake in a Uterine Subserosal Fibroid Mimicking Mesenteric Neuroendocrine Tumor : A Case StudyKamand Khalaj, Julie H Rowe, Chakradhar R Thupili, et al.
Targeted Oncology|April 19, 2011
Mammalian target of rapamycin as a target in hematological malignanciesKevin R Kelly, Julie H Rowe, Swaminathan Padmanabhan, et al.
Journal of Hepatocellular Carcinoma|April 2, 2026
Evaluation of Prophylactic EGD versus Beta Blockade in Hepatocellular Carcinoma Patients on Anti-Angiogenic Cancer TreatmentsPanayiotis D Kontoyiannis, Camila Ayerbe, Kok Hoe Chan, et al.
British Journal of Cancer|February 9, 2023
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancerJoan Jacob, Liezl E Francisco, Treena Chatterjee, et al.
Gastrointestinal Endoscopy|May 10, 2024
EUS-guided radiofrequency ablation for pancreatic adenocarcinomaCurtis J Wray, Baylee O'Brien, Putao Cen, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal CancerJoan Jacob, Yasuaki Anami, Peyton High, et al.
British Journal of Cancer|August 18, 2025
Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancerYukimatsu Toh, Ling Wu, Jianghua Tu, et al.
Pageof 2